Leukemia accounts for 9.6% share of global Oncology clinical trial activity in 2021
Leukemia accounted for a 9.6% share of the global clinical trials within the Oncology therapy area in 2021, registering a…
By
Market Data
Latest in
Market Data
Lymphoma accounts for 9.9% share of global Oncology clinical trial activity in 2021
Lymphoma accounted for a 9.9% share of the global clinical trials within the Oncology therapy area in 2021, registering a…
By
Prostate Cancer accounts for 4.3% share of global Oncology clinical trial activity in 2021
Prostate Cancer accounted for a 4.3% share of the global clinical trials within the Oncology therapy area in 2021, registering…
By
Ovarian Cancer accounts for 4.6% share of global Oncology clinical trial activity in 2021
Ovarian Cancer accounted for a 4.6% share of the global clinical trials within the Oncology therapy area in 2021, registering…
By
Pain accounts for 45.8% share of global Central Nervous System clinical trial activity in 2021
Pain accounted for a 45.8% share of the global clinical trials within the Central Nervous System therapy area in 2021,…
By
Psoriasis accounts for 17.2% share of global Immunology clinical trial activity in 2021
Psoriasis accounted for a 17.2% share of the global clinical trials within the Immunology therapy area in 2021, registering an…
By
Global clinical trials activity decreases 4.4% in Q2 2022 over 4Q average
The global clinical trials activity saw a decrease of 4.4% in Q2 2022, when compared with the rolling average of…
By
Global clinical trials activity decreases 7.6% YoY in Q2 2022
Global clinical trials activity decreased by 7.6% in Q2 2022, when compared with the same quarter in 2021, according to…
By